U.S. health officials have told more than a half-dozen of the nation’s top medical organizations that they will no longer ...

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...

The Trump FDA tries to kill a therapy that has helped boys with a deadly diagnosis.

Such appeasement efforts proved insufficient to protect him from rival forces in the Republican Party, if not also in the ...

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant leaf.

FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...

India has issued first official guidelines for expert panels to bring consistency, speed, and transparency to drug and device ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

George Tidmarsh is taking on more responsibilities at FDA after the sudden departure of top official Vinay Prasad.

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...